SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE
Exhibit 10.3
SEPARATION AND CONSULTING AGREEMENT AND GENERAL RELEASE
This Separation and Consulting Agreement and General Release (the “Agreement”) is being entered into between Xxxxxx Xxxxx (“Xxxxx”) and Marinus Pharmaceuticals, Inc. (the “Company”) in connection with Xxxxx’x separation from the Company effective March 9, 2021 (the “Separation Date”).
WHEREAS, Xxxxx’x employment with the Company is ending as of the Separation Date;
WHEREAS, the Company wishes to retain Xxxxx as a consultant for a period of time after the Separation Date to assist with the orderly transition of Xxxxx’x duties;
WHEREAS, the parties wish to clarify and memorialize certain agreements made between them in regard to such employment, termination of employment and consultancy period;
NOW, THEREFORE, in consideration of the foregoing premises and the terms stated herein, it is mutually agreed between the parties as follows:
a.Consideration Period; Deadline. Xxxxx acknowledges that he has been given a period of at least twenty-one (21) days to consider and execute this Agreement before signing it, and that no material changes have been made to this Agreement during the course of discussions leading up to the execution of this Agreement following January 29, 2021, the date this Agreement was first presented to Xxxxx. If Xxxxx fails to sign this Agreement and deliver it to the Company on the Separation Date this Agreement shall be deemed null and void. Xxxxx further acknowledges that he is hereby being advised in writing to consult with a competent, independent attorney of his choice, at his own expense, regarding the legal effect of this Agreement before signing it.
b.Revocation Deadline. Xxxxx understands and acknowledges that Xxxxx has seven (7) days following Xxxxx’x execution of this Agreement to revoke his release of ADEA claims in writing, and that should Xxxxx exercise that right, the Company has the option in its sole discretion of voiding the Agreement in its entirety, in which case the Company shall be relieved of all obligations to provide any benefits set forth in Section 3, and to the extent that Xxxxx already received benefits pursuant to those Sections he must immediately return them, except as otherwise stated in Section 3(d)(vii). This Agreement
shall be automatically effective and enforceable on the day following the expiration of the seven (7) day revocation period described in this Section 12(b) without Xxxxx’x revocation. For revocation to be effective, written notice must be delivered by email to the attention of Xxxx XxXxxxxx, Vice President Human Resources xxxxxxxxx@xxxxxxxxxxxxx.xxx, no later than 11:59 p.m. ET on the seventh (7th) calendar day after Xxxxx signs the Agreement.
[Execution Page to Follow]
FOR EXECUTION ON, BUT NOT BEFORE, MARCH 9, 2021
IN WITNESS WHEREOF, the undersigned, intending to be bound hereby, have agreed to the terms and conditions of this Agreement as of the date first set forth below.
XXXXXX XXXXX /s/ Xxxxxx Xxxxx Date: March 9, 2021 MARINUS PHARMACEUTICALS, INC. By: /s/ Xxxxx Braunsetin Name: Xxxxx Xxxxxxxxxx Title: Chief Executive Officer Date: March 9, 2021 | |
Schedule A
Schedule of Outstanding Stock Options that shall become Vested Effective as of the Separation Date
Grant Date | Exercise Price | Number of Shares Subject to Option Award (Exercisable) | Number of Shares Subject to Option Award (Unexercisable) | Number of Shares Subject to Option Award that shall become Vested Effective as of the Separation Date* |
11/25/2013 | $4.16 | 35,927 | | |
12/22/2014 | $34.80 | 15,500 | | |
7/20/2015 | $57.20 | 17,500 | | |
8/3/2016 | $6.00 | 14,350 | | |
1/7/2017 | $4.84 | 14,700 | | |
12/6/2017 | $24.76 | 50,000 | | |
2/26/2019 | $15.84 | 37,500 | 12,500 | 12,500 |
8/21/2019 | $4.48 | 7,917 | 7,083 | 7,083 |
1/8/2020 | $8.28 | 74,375 | 116,875 | 116,875 |
*The accelerated vesting of stock options set forth in this column is subject to Xxxxx’x satisfaction of the terms and conditions set forth in Section 4 of the Agreement to which this Schedule A is attached.